TNFα blockade in human diseases : An overview of efficacy and safety
- Author
- LIN, Jan1 ; ZIRING, David1 ; DESAI, Sheetal1 ; KIM, Sungjin1 ; WONG, Maida1 ; KORIN, Yael1 ; BRAUN, Jonathan1 ; REED, Elaine1 ; GJERTSON, David1 ; SINGH, Ram Raj1
[1] UCLA David Geffen School of Medicine, Los Angeles, CA 90095, United States - Source
Clinical immunology (Orlando, Fla. Print). 2008, Vol 126, Num 1, pp 13-30, 18 p ; ref : 125 ref
- CODEN
- CLIIFY
- ISSN
- 1521-6616
- Scientific domain
- Immunology, immunopathology, allergology; General medicine general surgery
- Publisher
- Elsevier, San Diego, CA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Adatimumab Ankylosing spendylitis Autoimmune diseases Biologic therapies Bronchial asthma Congestive heart failure Crohn's disease Cytokfnes Etancerceot Glomeru lonephritis Hepatitis Immunotherapy Infection Inflammatory bowel disease Inflammatory diseases Infliximab Juvenile idiopathic arthritis Multiple sclerosis Psoriasis Psoriatic arthritis Rheumatoid arthritis Sarcoidosis;
- Keyword (fr)
- Arthrite chronique juvénile Asthme Biothérapie Entérite de Crohn Facteur nécrose tumorale α Homme Hépatite Immunothérapie Infliximab Maladie autoimmune Maladie inflammatoire Polyarthrite rhumatoïde Psoriasis Rectocolite ulcérohémorragique Rhumatisme psoriasique Sarcoïdose Sclérose en plaques Toxicité Traitement Anti-TNF-alpha Anticorps monoclonal Anticytokine Appareil respiratoire Bronchopneumopathie obstructive Cardiopathie Immunopathologie Maladie de système Pathologie de l'appareil circulatoire Pathologie de l'appareil digestif Pathologie de l'appareil respiratoire Pathologie de l'intestin Pathologie de la peau Pathologie du foie Pathologie du système nerveux central Pathologie du système nerveux Pathologie du système ostéoarticulaire Rhumatisme inflammatoire Spondylarthropathie
- Keyword (en)
- Juvenile rheumatoid arthritis Asthma Biotherapy Crohn disease Tumor necrosis factor α Human Hepatitis Immunotherapy Infliximab Autoimmune disease Inflammatory disease Rheumatoid arthritis Psoriasis Ulcerative colitis Psoriatic arthritis Sarcoidosis Multiple sclerosis Toxicity Treatment Anti-Tumor Necrosis Factor-alpha Monoclonal antibody Anticytokine Respiratory system Obstructive pulmonary disease Heart disease Immunopathology Systemic disease Cardiovascular disease Digestive diseases Respiratory disease Intestinal disease Skin disease Hepatic disease Central nervous system disease Nervous system diseases Diseases of the osteoarticular system Inflammatory joint disease Spondylarthropathy
- Keyword (es)
- Artritis crónica juvenil Asma Bioterapia Enteritis Crohn Factor necrosis tumoral α Hombre Hepatitis Inmunoterapia Infliximab Enfermedad autoinmune Enfermedad inflamatoria Poliartritis reumatoidea Psoriasis Rectocolitis ulcerohemorrágica Reumatismo psoriásico Sarcoidosis Esclerosis en placa Toxicidad Tratamiento Anti-TNF alfa Anticuerpo monoclonal Anticitoquina Aparato respiratorio Enfermedad pulmonar obstructiva Cardiopatía Inmunopatología Enfermedad sistémica Aparato circulatorio patología Aparato digestivo patología Aparato respiratorio patología Intestino patología Piel patología Hígado patología Sistema nervosio central patología Sistema nervioso patología Sistema osteoarticular patología Reumatismo inflamatorio Espondilartropatia
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A06 Fundamental immunology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11B Chronic obstructive pulmonary disease, asthma
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A01 Heart failure, cardiogenic pulmonary edema, cardiac enlargement
- Discipline
- Cardiology. Circulatory system Fundamental immunology Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20001595
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.clim.2007.08.012 
https://dx.doi.org/10.1016/j.clim.2007.08.012
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.clim.2007.08.012\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical immunology (Orlando, Fla. Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Clin. immunol. (Orlando, Fla., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"30\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1521-6616\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Jan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"ZIRING, David\";i:1;s:14:\"DESAI, Sheetal\";i:2;s:12:\"KIM, Sungjin\";i:3;s:11:\"WONG, Maida\";i:4;s:11:\"KORIN, Yael\";i:5;s:15:\"BRAUN, Jonathan\";i:6;s:12:\"REED, Elaine\";i:7;s:15:\"GJERTSON, David\";i:8;s:14:\"SINGH, Ram Raj\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLIIFY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"18\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.clim.2007.08.012\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical immunology (Orlando, Fla. Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Clin. immunol. (Orlando, Fla., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"30\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1521-6616\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Jan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"ZIRING, David\";i:1;s:14:\"DESAI, Sheetal\";i:2;s:12:\"KIM, Sungjin\";i:3;s:11:\"WONG, Maida\";i:4;s:11:\"KORIN, Yael\";i:5;s:15:\"BRAUN, Jonathan\";i:6;s:12:\"REED, Elaine\";i:7;s:15:\"GJERTSON, David\";i:8;s:14:\"SINGH, Ram Raj\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLIIFY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"18\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.clim.2007.08.012\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.clim.2007.08.012\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical immunology (Orlando, Fla. Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Clin. immunol. (Orlando, Fla., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"30\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1521-6616\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Jan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"ZIRING, David\";i:1;s:14:\"DESAI, Sheetal\";i:2;s:12:\"KIM, Sungjin\";i:3;s:11:\"WONG, Maida\";i:4;s:11:\"KORIN, Yael\";i:5;s:15:\"BRAUN, Jonathan\";i:6;s:12:\"REED, Elaine\";i:7;s:15:\"GJERTSON, David\";i:8;s:14:\"SINGH, Ram Raj\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLIIFY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"18\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.clim.2007.08.012\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical immunology (Orlando, Fla. Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Clin. immunol. (Orlando, Fla., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"30\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1521-6616\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Jan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"ZIRING, David\";i:1;s:14:\"DESAI, Sheetal\";i:2;s:12:\"KIM, Sungjin\";i:3;s:11:\"WONG, Maida\";i:4;s:11:\"KORIN, Yael\";i:5;s:15:\"BRAUN, Jonathan\";i:6;s:12:\"REED, Elaine\";i:7;s:15:\"GJERTSON, David\";i:8;s:14:\"SINGH, Ram Raj\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLIIFY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"18\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.clim.2007.08.012\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical immunology (Orlando, Fla. Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Clin. immunol. (Orlando, Fla., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"30\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1521-6616\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Jan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"ZIRING, David\";i:1;s:14:\"DESAI, Sheetal\";i:2;s:12:\"KIM, Sungjin\";i:3;s:11:\"WONG, Maida\";i:4;s:11:\"KORIN, Yael\";i:5;s:15:\"BRAUN, Jonathan\";i:6;s:12:\"REED, Elaine\";i:7;s:15:\"GJERTSON, David\";i:8;s:14:\"SINGH, Ram Raj\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLIIFY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:69:\"TNF\u03b1 blockade in human diseases : An overview of efficacy and safety\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"18\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
